Answers are grounded in this paper and cite their sources.
Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disorder of unknown etiology and no preventive treatment. It is characterized by degeneration of both upper motoneurons in the primary motor cortex and lower motoneurons in the brainstem and spinal cord. It results in progressive muscular weakness and atrophy, leading eventually to respiratory insufficiency and death. Approximately 50% of patients with ALS die within 30 months of symptom onset (1). Although ALS is considered a rare disease (incidence between 0.6 and 2.6 new cases per year per 100,000, prevalence 3–8 per 100,000), it is in fact more common than generally recognized, with an adult lifetime risk of 1 in 400 (2). Approximately 10% of all ALS cases are familial (fALS), and the remaining 90% are sporadic (sALS). Genetic factors are involved in the pathogenesis of fALS and up to 15% of sALS (3, 4). Nowadays, the only established risk factors for ALS are advanced age, male gender, and certain genetic mutations (1). Given that no more than 25% of all ALS diagnosis has genetic basis, for the remaining percentage of cases gene–environmental interaction may be responsible. In the recent years, a vast number of studies addressing ALS risks related to the exposure to environmental factors have been published [for a recent review, see Ref. (5)]. Their analysis is difficult, since they applied various methods of data collection and analysis, from studying of toxicants’ content in tissue samples, through case–control studies and analysis of death certificates, to reviews and meta-analyses. Original studies were usually performed on small local patient cohorts, and their results are ambiguous and often contradictory. Virtually all so far published reviews on ALS risk factors were inconclusive and called for further investigations. Nevertheless, as mentioned earlier, at least 75% of ALS cases do not have established genetic basis, so the search for modifiable environmental factors continues. The research in this field is important, since it may lead to formulation of measures, which could prevent this fatal disease or at least delay its development. Therefore, we decided to put forward some thoughts that arose from studying published literature, hoping that they could help to design future successful studies on ALS risk factors.
No takes yet. Share an insight, caveat, or question.
Kuraszkiewicz et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: